Key Insights

Highlights

Success Rate

84% trial completion

Published Results

15 trials with published results (11%)

Research Maturity

56 completed trials (41% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

8.0%

11 terminated out of 138 trials

Success Rate

83.6%

-2.9% vs benchmark

Late-Stage Pipeline

7%

9 trials in Phase 3/4

Results Transparency

27%

15 of 56 completed with results

Key Signals

15 with results84% success11 terminated

Data Visualizations

Phase Distribution

92Total
Not Applicable (41)
Early P 1 (2)
P 1 (16)
P 2 (24)
P 3 (9)

Trial Status

Completed56
Unknown34
Recruiting22
Terminated11
Not Yet Recruiting8
Active Not Recruiting6

Trial Success Rate

83.6%

Benchmark: 86.5%

Based on 56 completed trials

Clinical Trials (138)

Showing 20 of 20 trials
NCT06023862Phase 2Recruiting

A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)

NCT07541859Not ApplicableNot Yet Recruiting

Breast and Cervical Cancer Awareness Training in Visually Impaired Women

NCT07011836Not ApplicableRecruitingPrimary

Video-Based Patient Navigation to Support Cervical Cancer Screening Among Black Women

NCT04389632Phase 1Recruiting

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

NCT04557423Not ApplicableCompletedPrimary

Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening

NCT04221945Phase 3CompletedPrimary

Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)

NCT06815939Not ApplicableRecruiting

Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer

NCT06400472Phase 1Recruiting

A Study of LY4170156 in Participants With Selected Advanced Solid Tumors

NCT00579163Active Not Recruiting

Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers

NCT07305727RecruitingPrimary

A Radiomic MRI Predictive Model for Response to Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer

NCT04579380Phase 2Active Not Recruiting

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

NCT07240753Not Yet RecruitingPrimary

A Chinese Cohort of Cervical Large Cell Neuroendocrine Carcinoma

NCT07214506Not ApplicableNot Yet RecruitingPrimary

Human Papillomavirus (HPV) Self-Sampling Options to Promote Equity

NCT07202936RecruitingPrimary

Cervical Pre-cancer Treatment Failure Among Women Living With HIV in Zimbabwe

NCT07204535Not Yet RecruitingPrimary

Post-TRaUmatic STress Disorder Induced by Gynecological Brachytherapy

NCT05007106Phase 2CompletedPrimary

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)

NCT04694495Completed

HPV Infection and Genital Microecology of Childbearing-age Female in China: A Cohort and Multicenter Study

NCT07015593Not Yet Recruiting

Patient Journey in Advanced Gynecologic Cancers

NCT05944237Phase 1Recruiting

HTL0039732 in Participants With Advanced Solid Tumours

NCT06984289CompletedPrimary

US Radiomics in Advanced Cervical Cancer

Scroll to load more

Research Network

Activity Timeline